NIH trial found experimental therapy also reduced most children’s sensitivity to peanut — ScienceDa…

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a…

Click here to view the original article.